Bausch + Lomb Corporation, an eye health company responsible for producing popular contact lens brands like Biotrue and Soflens, is planning to go public. Here's what we know—and how to buy Bausch + Lomb Corporation stock in Canada when it launches.
How to buy Bausch + Lomb Corporation stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BLCO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Bausch + Lomb Corporation?
- Bausch + Lomb Corporation shares summary
- Compare share dealing platforms
- Is Bausch + Lomb Corporation stock a buy or sell?
- Bausch + Lomb Corporation performance over time
- Are Bausch + Lomb Corporation shares over-valued?
- Bausch + Lomb Corporation's financials
- Does Bausch + Lomb Corporation pay a dividend?
- Other common questions
Bausch + Lomb Corporation stock price (NYSE:BLCO)
Use our graph to track the performance of BLCO stocks over time.Bausch + Lomb Corporation shares at a glance
Latest market close | $17.94 |
---|---|
52-week range | $15.90 - $20.20 |
50-day moving average | $17.27 |
200-day moving average | $17.27 |
Wall St. target price | $35.00 |
PE ratio | 33.82 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.50 |
Buy Bausch + Lomb Corporation stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Bausch + Lomb Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Bausch + Lomb Corporation price performance over time
Historical closes compared with the close of $17.94 from 2023-05-26
1 week (2023-05-23) | -6.22% |
---|---|
1 month (2023-04-28) | 2.75% |
3 months (2023-03-02) | 1.53% |
6 months (2022-11-30) | 18.57% |
1 year (2022-05-27) | 1.41% |
---|---|
2 years (2021-05-26) | N/A |
3 years (2020-05-26) | N/A |
5 years (2018-05-26) | N/A |
Is Bausch + Lomb Corporation stock undervalued or overvalued?
Valuing Bausch + Lomb Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch + Lomb Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bausch + Lomb Corporation financials
Revenue TTM | $3.8 billion |
---|---|
Operating margin TTM | 8.38% |
Gross profit TTM | $2.3 billion |
Return on assets TTM | 0% |
Return on equity TTM | 2.16% |
Profit margin | 4.64% |
Book value | $20.40 |
Market capitalisation | $5.9 billion |
TTM: trailing 12 months
Bausch + Lomb Corporation share dividends
We're not expecting Bausch + Lomb Corporation to pay a dividend over the next 12 months.
Bausch + Lomb Corporation overview
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments and treatments for various eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases; and and contact lenses for therapeutic use. The Surgical segment provides medical device equipment, consumables, and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions. The company was founded in 1853 and is headquartered in Vaughan, Canada. .
Stocks similar to Bausch + Lomb Corporation
Bausch + Lomb Corporation in the news
15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn
The 6.3% return this week takes Bausch + Lomb's (NYSE:BLCO) shareholders one-year gains to 18%
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
-
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
-
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
-
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
-
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
-
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.